OBP2B
Odorant-binding protein 2b
Also known as: hOBPIIb, LCN14, OBP2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPH6
- Gene
- OBP2B
- Ensembl
- ENSG00000171102
- Chromosome
- 9
- Canonical length
- 170 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Predicted to enable odorant binding activity. Predicted to be involved in chemosensory behavior and sensory perception of smell. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
170 residues, UniProt reviewed canonical sequence.
>Q9NPH6|OBP2B
1 MKTLFLGVTL GLAAALSFTL EEEDITGTWY VKAMVVDKDF PEDRRPRKVS PVKVTALGGG
61 KLEATFTFMR EDRCIQKKIL MRKTEEPGKY SAYGGRKLMY LQELPRRDHY IFYCKDQHHG
121 GLLHMGKLVG RNSDTNREAL EEFKKLVQRK GLSEEDIFTP LQTGSCVPEHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OBP2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 9.4 nTPM
Expression across tissuesHPA
Tissue
- testis: 9.4 nTPM
- skin: 2.4 nTPM
- breast: 1.6 nTPM
- fallopian tube: 0.9 nTPM
- endometrium: 0.5 nTPM
- ovary: 0.1 nTPM
Single-cell type
- breast secretory cells: 14 nCPM
- sertoli cells: 13 nCPM
- fallopian secretory cells: 7.1 nCPM
- granulosa cells: 6.5 nCPM
- epididymal principal cells: 5.3 nCPM
- breast hormone-responsive cells: 4.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.55
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OBP2B as an antibody target. Whether an autoantibody or antibody against OBP2B could matter depends on whether native OBP2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OBP2B is annotated as secreted, so native OBP2B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label OBP2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...